about
Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats.Aminoguanidine prevents fructose-induced deterioration in left ventricular-arterial coupling in Wistar rats.Aminoguanidine prevents the impairment of cardiac pumping mechanics in rats with streptozotocin and nicotinamide-induced type 2 diabetesThe correlation of cardiac mass with arterial haemodynamics of resistive and capacitive load in rats with normotension and established hypertension.Effects of acetyl-L-carnitine and oxfenicine on aorta stiffness in diabetic rats.Enhanced expression of cardiac nerve growth factor and nerve sprouting markers in rats following gastric perforation: the association with cardiac sympathovagal balance.Arterial stiffening and cardiac hypertrophy in a new rat model of type 2 diabetes.Quantification of contractile mechanics in the rat heart from ventricular pressure alone.Exponentially tapered T-tube model in the characterization of arterial non-uniformity.Impedance and wave reflection in arterial system: simulation with geometrically tapered T-tubes.Exponentially tapered t-tube model of systemic arterial system in dogs.Impaired vascular dynamics in normotensive diabetic rats induced by streptozotocin: tapered T-tube model analysis.Hypertensive effects of methoxamine on arterial mechanics in rats: analysis based on exponentially tapered T-tube model.Research update for articles published in EJCI in 2010Theoretical maximal flow of the left ventricle is sensitive to change in ventricular afterloadAminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetesPyridoxamine prevents age-related aortic stiffening and vascular resistance in association with reduced collagen glycationEnhanced aortic nerve growth factor expression and nerve sprouting in rats following gastric perforationQuantification of cardiac pumping mechanics in rats by using the elastance-resistance model based solely on the measured left ventricular pressure and cardiac output
P50
Q35566544-5E19E355-99E5-4B0F-99D7-B2B83EF83E49Q36052796-F72E535D-4CF3-4C10-A50D-5B8301E8A2C6Q36736336-1215BFB4-3A1E-4C3E-9D09-CC6B7FC9018EQ42689063-140D7832-356C-486D-8331-AEDB504528B8Q42949448-C7329AAE-2C4B-4080-A6C7-69F2479EF5D4Q45986960-9D46DBA2-A030-4A37-AB25-E1E94793F808Q46887126-A194D5BC-8B8F-4A5D-9099-CF8293395C71Q47115374-07DE693A-1896-4F60-ADF4-F3ED1F5AC7E6Q52291125-AAE2FD9E-E8BB-4136-88C9-1F8C99639934Q52331163-51ADD4D5-BAF2-434F-B575-066B741AF3AEQ52371915-FCEDDC9F-C1BE-40E7-8EC5-E6C54FA8FB39Q54051140-87DFCE01-3C6B-47A0-ACDE-51E93250232CQ54129013-E692AED4-4E99-4F7F-832B-433E8CE65DF7Q57601993-F7F892CA-B943-402C-B102-2BF5C6E401B2Q77431536-1408943C-C9F9-4980-9D83-F86FF8CC69BCQ80069624-932CB7B1-6A21-4BB2-851A-E81C38DDE458Q83400845-BB7162A2-54E0-498D-BF18-9862B6E7492BQ84691941-38563E89-81EA-4DD8-9486-FD77BB744D9CQ92575645-4A03C095-1400-4CAD-B34F-F527D5D0E24F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kuo-Chu Chang
@ast
Kuo-Chu Chang
@en
Kuo-Chu Chang
@es
Kuo-Chu Chang
@nl
type
label
Kuo-Chu Chang
@ast
Kuo-Chu Chang
@en
Kuo-Chu Chang
@es
Kuo-Chu Chang
@nl
prefLabel
Kuo-Chu Chang
@ast
Kuo-Chu Chang
@en
Kuo-Chu Chang
@es
Kuo-Chu Chang
@nl
P106
P1153
55702955100
P31
P496
0000-0002-4421-5711